Current Affairs   »   Canada approved world’s 1st plant-derived COVID-19...   »   Canada approved world’s 1st plant-derived COVID-19...

Canada approved world’s 1st plant-derived COVID-19 vaccine

Canada approved world's 1st plant-derived COVID-19 vaccine_50.1

Canada became the first country in the world that has authorized the use of a plant-based COVID-19 vaccine. The two-dose vaccine of Medicago Inc. (a biopharma company owned by Mitsubishi Chemical and Philip Morris), can be given to adults who are aged between 18 to 64, but little data is available on the shots received by people aged 65 and above.

Buy Prime Test Series for all Banking, SSC, Insurance & other exams

The decision to authorize the vaccine was based on a study conducted on 24,000 adults that showed the efficacy rate of the vaccine is 71% at preventing COVID-19 – although the tests were conducted before the omicron variant emerged. Covifenz is the name given to this vaccine. Canada agreed to buy 20 million doses of this plant-based vaccine, with an option to purchase 56 million additional doses.

Important takeaways for all competitive exams:

  • Canada Capital: Ottawa;
  • Canada Currency: Canadian dollar;
  • Canada Prime minister: Justin Trudeau.

Find More International News

Canada approved world's 1st plant-derived COVID-19 vaccine_60.1

Canada approved world's 1st plant-derived COVID-19 vaccine_70.1

Thank You, Your details have been submitted we will get back to you.
Was this page helpful?

Leave a comment

Your email address will not be published. Required fields are marked *